Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/18/2003CA2478572A1 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003CA2478479A1 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003CA2478346A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
09/18/2003CA2478169A1 Human antibodies specific to kdr and uses thereof
09/18/2003CA2478125A1 Avian cell lines for the production of useful substances
09/18/2003CA2478120A1 Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto
09/18/2003CA2478116A1 Neoplasm specific antibodies and uses thereof
09/18/2003CA2478107A1 Surgical device for skin therapy or testing
09/18/2003CA2477975A1 Novel vip3 toxins and methods of use
09/17/2003EP1344827A2 Antifreeze proteins from basidiomycetes
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344819A2 Human hematopoietic stem cell
09/17/2003EP1344818A1 Method for culturing Langerhans islets cells
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1344057A2 Organ system microarrays
09/17/2003EP1343902A2 Recombinant porcine liver esterases, their use and a method for the production thereof
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343898A1 Novel thermostable galactose isomerase and tagatose production thereby
09/17/2003EP1343897A2 Purified active hcv ns2/3 protease
09/17/2003EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments
09/17/2003EP1343891A2 Colon cancer marker
09/17/2003EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/17/2003EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
09/17/2003EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343884A2 Jfy1 protein induces rapid apoptosis
09/17/2003EP1343883A2 Aspergillus fumigatus cofilin
09/17/2003EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
09/17/2003EP1343879A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
09/17/2003EP1343875A2 Sugar beet genes involved in stress tolerance
09/17/2003EP1343872A2 Culturing tissue using magnetically generated mechanical stresses
09/17/2003EP1343871A2 Isolation and use of solid tumor stem cells
09/17/2003EP1343822A2 Means for the diagnosis and therapy of ctcl
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343812A1 Protein cluster ii
09/17/2003EP1343536A1 Method for decellularising foreign material for the production of bioprostheses
09/17/2003EP1343369A1 Preservation of cells
09/17/2003EP1187530B1 Improved storage and maintenance of blood products including red blood cells and platelets
09/17/2003EP1060242A4 Purified populations of stem cells
09/17/2003EP1019482A4 Soaps produced from high laurate canola oil-based fatty acids
09/17/2003EP0981627B1 Purified telomerase
09/17/2003EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
09/17/2003EP0812201B1 In vitro amplification of stem cells
09/17/2003EP0669988B1 Angiogenesis inhibitory antibodies
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443243A 修饰的病毒 Modified viruses
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443240A Interferon-like protein zcyto 21
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443236A Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443077A CD40-binding APC-activating molecules
09/17/2003CN1443074A Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
09/17/2003CN1442479A Mammalian engineering cell line for production of hantan virus granules
09/17/2003CN1442478A Improved method for invitro growth of mammalian cell
09/17/2003CN1121496C Method for culturing anchorage dependent animal cell to produce virus by using magnetic stable fluidized bed
09/17/2003CN1121430C Cell growth substrate polymer
09/16/2003US6620990 Incubating explant, in the presence of a vector comprising DNA encoding a selectable marker, to produce callus; confers chemical/antibiotic/herbicide resistance
09/16/2003US6620923 Use for treatment of uterine cancer
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620912 Novel human protein of given nucleotide sequence; vectors, host cells, antibodies, and recombinant methods; for diagnosis and treatment of disorders including those in the immune system
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620618 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines
09/16/2003US6620616 Nucleic acids encoding nitric oxide synthase variants
09/16/2003US6620608 Peptides for use in the treatment of cholesterol defects
09/16/2003US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders
09/16/2003US6620599 Process for the production of a biologically active phenolic compound(+) catechin
09/16/2003US6620595 Retroviral vectors comprising an enhanced 3′ transcription termination structure
09/16/2003US6620203 Tissue engineered testicular prosthesis and use thereof
09/16/2003CA2140252C A snow grooming device
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/12/2003WO2003074721A2 Method for producing riboflavin
09/12/2003WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074692A2 Specific gene expression in colonic cancer cell lines
09/12/2003WO2003074691A1 Immobilized cells and liposomes and method of immobilizing the same
09/12/2003WO2003074686A1 HELPER CONSTRUCTS FOR PRODUCING HYBRID rAAV PARTICLES OF VARIOUS AAV SEROTYPES
09/12/2003WO2003074685A2 Il-10 gene transfer to peripheral blood mononuclear cells
09/12/2003WO2003074684A1 Cells capable of differentiating into myocardium-like cells
09/12/2003WO2003074683A1 Cmos process-compatible high dielectric constant surface coating for the detection and stimulation of biological tissue
09/12/2003WO2003074670A2 Lis promoter for expression of transgenes in floral tissues
09/12/2003WO2003074668A2 Models of cellular development using homozygous stem cells
09/12/2003WO2003074659A2 Magnetic immobilization of cells
09/12/2003WO2003074565A2 Peptides for use in antitumor immunotherapy
09/12/2003WO2003074563A2 Means and methods for manipulating hypersensitivity-like responses
09/12/2003WO2003074559A1 Falp proteins
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003074099A1 Base material for tissue regeneration, transplantation material and process for producing the same
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074077A1 Purification of red blood cells by separation and diafiltration
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074007A2 Modulators of leukocyte activation, compositions, and methods of use
1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 1827